H.R. 4400
Referred to CommitteeAdvancing Education on Biosimilars Act of 2019
Latest Action
Referred to the Subcommittee on Health.
9/20/2019 • House
Summary
Advancing Education on Biosimilars Act of 2019
This bill requires the Department of Health and Human Services (HHS) to maintain a website and undertake other activities to educate health care providers, patients, and caregivers about biological products, biosimilar biological products, and interchangeable biosimilar biological products.
Among other activities, HHS must develop or improve continuing education programs that address clinical considerations for biological and related products. Health care providers eligible for the Merit-based Incentive Payment System in Medicare may count completion of such a program as a clinical practice improvement activity.
Introduced in House • 9/19/2019
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
Sponsor
Cosponsors (1)
Bill Journey
Originated in the House
Introduced
September 19, 2019
Referred to the Subcommittee on Health.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law